A double-blind comparison of venlafaxine and fluoxetine in patients hospitalized for major depression and melancholia

International Clinical Psychopharmacology

Volumn 9, Issue 3, 1994, Pages 139-143

  Clerc, G E ^a   Ruimy, P ^b   Verdeau Pailles J ^b  

^a CENTRE HOSPITALIER   (France)

^b NONE

Author keywords

Depression; Fluoxetine; Hospitalized patients; Melancholia; Venlafaxine

Indexed keywords

FLUOXETINE; VENLAFAXINE;

ADULT; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DEPRESSION; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG SAFETY; DRUG TOLERANCE; FEMALE; HEADACHE; HOSPITALIZATION; HUMAN; INSOMNIA; MAJOR CLINICAL STUDY; MALE; MELANCHOLIA; MULTICENTER STUDY; NAUSEA; PRIORITY JOURNAL; XEROSTOMIA;

ANTIDEPRESSIVE AGENTS, SECOND-GENERATION; CYCLOHEXANOLS; DEPRESSIVE DISORDER; DOSE-RESPONSE RELATIONSHIP, DRUG; DOUBLE-BLIND METHOD; DRUG ADMINISTRATION SCHEDULE; FEMALE; FLUOXETINE; HOSPITALIZATION; HUMANS; MALE; MIDDLE AGED; PERSONALITY INVENTORY;

EID: 0028075486     PISSN: 02681315     EISSN: 14735857     Source Type: Journal    
DOI: 10.1097/00004850-199409000-00001     Document Type: Article

References (14)

1. American Psychiatric Association (1987) Diagnostic and Statistical Manual of Mental Disorders, 3rd edn, revised. American Psychiatric Association, Washington, DC.
2. American Psychiatric Assocíation Practice Guideline for Major Depressive Disorder in Adults (1993) American Journal of Psychiatry, 150(Suppl.), 1–26.
3. Baron BM, Ogden AM, Siegel BW, Stegeman J, Ursillo RC and Dudley MW (1988) Rapid down regulation of β-adrenorecep- tors by co-administration of desipramine and fluoxetine. European Journal of Pharmacology, 154, 125–134.
4. Beasley CM Jr, Holman SL and Potvin JH (1993) Fluoxetine compared with imipramine in the treatment of inpatient depression. A multicenter trial. Annals of Clinical Psychiatry, 5, 199–207.
5. Brunello N, Barbaccia ML, Chuang DM and Costa E (1982) Down regulation of β-adrenergic receptors following repeated injections of desmethylimipramine: permissive role of serotonergic axons. Neuropharmacology, 21, 1145–1149.
6. Guelfi JD, White C and Magni G (1992) A randomized doubleblind comparison of venlafaxine and placebo in ínpatients with major depression and melancholia (Abstract). Clinical Neuropharmacology, 15(suppl. 1, part B), 323B.
7. Janowsky A, Okada F, Manier DH, Applegate C, Sulser F and Steranka L (1982) Role of serotonergic input in the regulation of the beta-adrenergíc receptor-coupled adenylate cyclase system. Science, 218, 900–901.
8. Kasper S, Fuger J and Möller H-J (1992) Comparative efficacy of antidepressants. Drugs, 43(Suppl. 2), 11–23.
9. Kocsis JH, Croughan JL, Katz MM, Butler TP, Secunda S, Bowden CL and Davis JM (1990) Response to treatment with antidepressants of patients with severe or moderate nonpsychotie depression and of patients with psychotic depression. American Journal of Psychiatry, 147, 621–624.
10. Muth EA, Haskins JT, Moyer JA, Husbands GEM, Nielsen ST and Sigg EB (1986) Antidepressant biochemical profile of the novel bicyclic compound Wy-45,030, an ethyl cyclohexanol derivative. Biochemical Pharmacology, 35, 4493–4497.
11. Nelson JC, Mazure CM, Bowers MB Jr and Jatlow PI (1991) A preliminary, open study of the combination of fluoxetine and desipramìne for rapid treatment of major depression. A rchives of General Psychîatry, 48, 303–307.
12. Pande AC and Sayler ME (1993) Severity of depression and response to fluoxetine. International Clinical Psvchopharmacology, 8, 243–245.
13. Stark P and Hardison CD (1985) A review of multicenter controlled studies of fluoxetine vs. imípramine and placebo in outpatients wíth major depression. Journal of Clinical Psychiatry, 46, 53–58.
14. Stokes PE (1993) Fluoxetine: a five-year review. Clinical Ther, 15,216–243.